FI924370A - Karbamatderivat av 4-amino-3-isoxazolidinoner, 3-amino-1-hydroxipyrrolidin-2-oner och 1-amino-1-cyklopropankarboxylsyraanaloger, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel - Google Patents
Karbamatderivat av 4-amino-3-isoxazolidinoner, 3-amino-1-hydroxipyrrolidin-2-oner och 1-amino-1-cyklopropankarboxylsyraanaloger, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel Download PDFInfo
- Publication number
- FI924370A FI924370A FI924370A FI924370A FI924370A FI 924370 A FI924370 A FI 924370A FI 924370 A FI924370 A FI 924370A FI 924370 A FI924370 A FI 924370A FI 924370 A FI924370 A FI 924370A
- Authority
- FI
- Finland
- Prior art keywords
- amino
- isoxazolidinoner
- hydroxipyrrolidin
- fremstaellning
- cyclopropankarboxylsyraanaloger
- Prior art date
Links
- AFCCDDWKHLHPDF-UHFFFAOYSA-M metam-sodium Chemical compound [Na+].CNC([S-])=S AFCCDDWKHLHPDF-UHFFFAOYSA-M 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- PAJPWUMXBYXFCZ-UHFFFAOYSA-N 1-aminocyclopropanecarboxylic acid Chemical class OC(=O)C1(N)CC1 PAJPWUMXBYXFCZ-UHFFFAOYSA-N 0.000 abstract 1
- HCKUBNLZMKAEIN-UHFFFAOYSA-N 3-amino-1-hydroxypyrrolidin-2-one Chemical class NC1CCN(O)C1=O HCKUBNLZMKAEIN-UHFFFAOYSA-N 0.000 abstract 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000007074 memory dysfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Fats And Perfumes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI953443A FI953443A (fi) | 1991-10-01 | 1995-07-14 | Menetelmä terapeuttisesti käyttökelpoisten 4-amino-3-isoksatsolidinonien ja 3-amino-1-hydroksipyrroilidin-2-onien karbamaattijohdannaisten valmistamiseksi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/769,268 US5153193A (en) | 1991-10-01 | 1991-10-01 | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI924370A0 FI924370A0 (fi) | 1992-09-29 |
| FI924370A true FI924370A (fi) | 1993-04-02 |
| FI102178B FI102178B (fi) | 1998-10-30 |
| FI102178B1 FI102178B1 (fi) | 1998-10-30 |
Family
ID=25084962
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924370A FI102178B1 (fi) | 1991-10-01 | 1992-09-29 | Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo[2,3-b]indol-5-yylijohdannaisten valmistamiseksi |
| FI981710A FI981710A0 (fi) | 1991-10-01 | 1998-08-06 | Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI981710A FI981710A0 (fi) | 1991-10-01 | 1998-08-06 | Terapeuttisesti käyttökelpoiset 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yylijohdannaiset |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5153193A (fi) |
| EP (2) | EP1069125A3 (fi) |
| JP (1) | JP2703157B2 (fi) |
| KR (2) | KR100276143B1 (fi) |
| AT (1) | ATE201024T1 (fi) |
| AU (1) | AU649882B2 (fi) |
| CA (1) | CA2079548C (fi) |
| CZ (1) | CZ281982B6 (fi) |
| DE (1) | DE69231817T2 (fi) |
| DK (1) | DK0535645T3 (fi) |
| ES (1) | ES2157201T3 (fi) |
| FI (2) | FI102178B1 (fi) |
| GR (1) | GR3036334T3 (fi) |
| HU (1) | HU215120B (fi) |
| IL (1) | IL103304A (fi) |
| MX (1) | MX9205577A (fi) |
| NO (1) | NO301884B1 (fi) |
| NZ (1) | NZ244540A (fi) |
| PT (1) | PT535645E (fi) |
| RU (1) | RU2103271C1 (fi) |
| TW (1) | TW208009B (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231093A (en) * | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| IT1253007B (it) * | 1991-12-31 | 1995-07-10 | Aesculapius Farma Srl | Derivati dell'eserolina ad attivita' anticolinesterasica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono |
| US5480651A (en) * | 1992-03-16 | 1996-01-02 | Regents Of The University Of California | Composition and method for treating nicotine craving in smoking cessation |
| US6323195B1 (en) | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
| US6323196B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
| US6316439B1 (en) * | 1993-10-15 | 2001-11-13 | Aventis Pharamaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
| AT403803B (de) * | 1996-04-19 | 1998-05-25 | Sanochemia Ltd | Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln |
| US5665880A (en) * | 1996-10-31 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseretholes |
| US5677457A (en) * | 1996-12-19 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
| ES2211056T3 (es) * | 1999-03-31 | 2004-07-01 | Eisai Co., Ltd. | Composiciones estabilizadas que contienen farmacos nootropicos. |
| PL202463B1 (pl) * | 2000-03-31 | 2009-06-30 | Sanochemia Pharmazeutika Ag | Pochodne galantaminy, sposób ich wytwarzania, środek leczniczy zawierajacy te pochodne, zastosowanie pochodnej galantaminy do wytwarzania środków leczniczych, sposób wytwarzania środków leczniczych oraz sposób oddzielania (+)- i (-)-izomerów |
| AU2001217709B2 (en) * | 2000-11-16 | 2005-10-13 | Alcon Manufacturing, Ltd. | Combination therapy for lowering and controlling intraocular pressure |
| WO2005042475A2 (en) * | 2003-10-21 | 2005-05-12 | Sention, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| US7549431B1 (en) * | 2004-11-10 | 2009-06-23 | Gore Enterprise Holdings, Inc. | Protective enclosure |
| TWI487486B (zh) | 2009-12-01 | 2015-06-11 | Syngenta Participations Ag | 以異唑啉衍生物為主之殺蟲化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1974782U (de) | 1967-07-04 | 1967-12-14 | Filzfabrik Fulda G M B H & Co | Matratzenschoner. |
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| ATE411026T1 (de) * | 1987-05-04 | 2008-10-15 | Bonnie Davis | Mittel zur behandlung der alzheimer-krankheit |
| GB8727792D0 (en) | 1987-11-27 | 1987-12-31 | Merck Sharp & Dohme | Therapeutic agents |
| GB8823605D0 (en) * | 1988-10-07 | 1988-11-16 | Merck Sharp & Dohme | Therapeutic agents |
| US5187171A (en) * | 1989-01-09 | 1993-02-16 | G. D. Searle & Co. | Use of a glycine b partial agonist as an antipsychotic |
| US5061721A (en) * | 1989-03-15 | 1991-10-29 | G. D. Searle & Co. | Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
-
1991
- 1991-10-01 US US07/769,268 patent/US5153193A/en not_active Expired - Fee Related
-
1992
- 1992-09-21 TW TW081107422A patent/TW208009B/zh active
- 1992-09-29 FI FI924370A patent/FI102178B1/fi active
- 1992-09-29 NZ NZ244540A patent/NZ244540A/en unknown
- 1992-09-30 NO NO923803A patent/NO301884B1/no not_active IP Right Cessation
- 1992-09-30 EP EP00121827A patent/EP1069125A3/en not_active Withdrawn
- 1992-09-30 IL IL10330492A patent/IL103304A/en not_active IP Right Cessation
- 1992-09-30 JP JP4261196A patent/JP2703157B2/ja not_active Expired - Fee Related
- 1992-09-30 DE DE69231817T patent/DE69231817T2/de not_active Expired - Fee Related
- 1992-09-30 DK DK92116760T patent/DK0535645T3/da active
- 1992-09-30 EP EP92116760A patent/EP0535645B1/en not_active Expired - Lifetime
- 1992-09-30 KR KR1019920017878A patent/KR100276143B1/ko not_active IP Right Cessation
- 1992-09-30 AT AT92116760T patent/ATE201024T1/de not_active IP Right Cessation
- 1992-09-30 MX MX9205577A patent/MX9205577A/es not_active IP Right Cessation
- 1992-09-30 RU SU5052874A patent/RU2103271C1/ru active
- 1992-09-30 PT PT92116760T patent/PT535645E/pt unknown
- 1992-09-30 CZ CS922990A patent/CZ281982B6/cs not_active IP Right Cessation
- 1992-09-30 AU AU26065/92A patent/AU649882B2/en not_active Ceased
- 1992-09-30 ES ES92116760T patent/ES2157201T3/es not_active Expired - Lifetime
- 1992-09-30 CA CA002079548A patent/CA2079548C/en not_active Expired - Fee Related
- 1992-10-01 HU HU9203129A patent/HU215120B/hu not_active IP Right Cessation
-
1998
- 1998-08-06 FI FI981710A patent/FI981710A0/fi unknown
-
2000
- 2000-01-27 KR KR1020000004035A patent/KR100271416B1/ko not_active IP Right Cessation
-
2001
- 2001-08-07 GR GR20010401186T patent/GR3036334T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI924370A (fi) | Karbamatderivat av 4-amino-3-isoxazolidinoner, 3-amino-1-hydroxipyrrolidin-2-oner och 1-amino-1-cyklopropankarboxylsyraanaloger, foerfarande foer framstaellning av dessa och anvaendning av dessa som laekemedel | |
| ES2040261T3 (es) | Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos. | |
| ATE170510T1 (de) | 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel | |
| ATE192446T1 (de) | Kondensierte benzoxa-ringverbindung, deren herstellung sowie diese enthaltendes arzneimittel | |
| NO943895D0 (no) | Galantaminderivater, en fremgangsmåte for fremstilling samt deres anvendelse som medikamenter | |
| ATE70842T1 (de) | Bakterizide pyridobenzothiazinderivate mit langer wirkungsdauer. | |
| ES2033256T3 (es) | Procedimiento para preparar derivados fluorados de la vitamina d3. | |
| NO903291D0 (no) | Renin-hemmende aminooligohydroksy-derivater. | |
| FI933928A0 (fi) | Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel | |
| TH4059A (th) | สารประกอบต่าง ๆ สำหรับรักษาโรค |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: HOECHST MARION ROUSSEL, INC. |